The present results demonstrate that CD4+ T cells activated in the primary in vivo response to antigen produce distinct patterns of cytokines depending upon the MHC class II haplotype of the responding mice. I-As mice were found to selectively activate IL-2/IFN-gamma-producing CD4+ T cells, whereas I-Ab mice exhibited selective activation of IL-4-producing CD4+ T cells in response to collagen IV. The effector response phenotype was found to correlate with the cytokine phenotype of CD4+ T cells activated in vivo; IL-2/IFN-gamma-producing cells giving rise to proliferative (cell-mediated) responses, IL-4-producing cells leading to secondary IgG (humoral) responses. Together the data support the notion that the outcome of a given immune response (e.g., protection vs. onset, tolerance vs. autoimmunity) may be determined in part by the type of CD4+ T cells initially activated by antigen. Moreover, the present experiments demonstrate for the first time that polymorphism in class II MHC can determine such selective activation of different cytokine-producing CD4+ T cell phenotypes.
Skip Nav Destination
Article navigation
1 December 1989
Article|
December 01 1989
MHC control of CD4+ T cell subset activation.
J S Murray,
J S Murray
Section of Immunobiology, Howard Hughes Medical Institute Yale University School of Medicine, New Haven, Connecticut 06510.
Search for other works by this author on:
J Madri,
J Madri
Section of Immunobiology, Howard Hughes Medical Institute Yale University School of Medicine, New Haven, Connecticut 06510.
Search for other works by this author on:
J Tite,
J Tite
Section of Immunobiology, Howard Hughes Medical Institute Yale University School of Medicine, New Haven, Connecticut 06510.
Search for other works by this author on:
S R Carding,
S R Carding
Section of Immunobiology, Howard Hughes Medical Institute Yale University School of Medicine, New Haven, Connecticut 06510.
Search for other works by this author on:
K Bottomly
K Bottomly
Section of Immunobiology, Howard Hughes Medical Institute Yale University School of Medicine, New Haven, Connecticut 06510.
Search for other works by this author on:
J S Murray
Section of Immunobiology, Howard Hughes Medical Institute Yale University School of Medicine, New Haven, Connecticut 06510.
J Madri
Section of Immunobiology, Howard Hughes Medical Institute Yale University School of Medicine, New Haven, Connecticut 06510.
J Tite
Section of Immunobiology, Howard Hughes Medical Institute Yale University School of Medicine, New Haven, Connecticut 06510.
S R Carding
Section of Immunobiology, Howard Hughes Medical Institute Yale University School of Medicine, New Haven, Connecticut 06510.
K Bottomly
Section of Immunobiology, Howard Hughes Medical Institute Yale University School of Medicine, New Haven, Connecticut 06510.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1989) 170 (6): 2135–2140.
Citation
J S Murray, J Madri, J Tite, S R Carding, K Bottomly; MHC control of CD4+ T cell subset activation.. J Exp Med 1 December 1989; 170 (6): 2135–2140. doi: https://doi.org/10.1084/jem.170.6.2135
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement